empagliflozin
boehringer ingelheim,eli lilly
['empagliflozin', 'cardio']
 reveals #sglt2i mechanism benefits in #heartfailure - cardio + nephroprotective induced by #empagliflozin due to effects on #autophagy #renal #inflammation #fibrosis sglt2i drugs again the hot drug class at #esccongress as they clinically benefit #cardiometabolism 
Flagship #OpenAccess medical journal from @BioMedCentral. Publishes research articles & reviews in all areas of research & practice in #medicine & #globalhealth